Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 1 2Phase 2 1

Status

Completed 108Recruiting 51Unknown 41Terminated 37Active not recruiting 16Withdrawn 9Not yet recruiting 6Suspended 4Enrolling by invitation 1

Sponsor Class

OTHER 5OTHER_GOV 1

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Lymphoid 6Dermatologic 1

Conditions

Breast Neoplasms 549Neoplasms 384Carcinoma, Non-Small-Cell Lung 319Colorectal Neoplasms 290Lung Neoplasms 239Prostatic Neoplasms 219Carcinoma, Hepatocellular 212Stomach Neoplasms 158Pancreatic Neoplasms 151Leukemia, Myeloid, Acute 139Multiple Myeloma 130Uterine Cervical Neoplasms 127Recurrence 116Rectal Neoplasms 112Ovarian Neoplasms 105Neoplasm Metastasis 104Squamous Cell Carcinoma of Head and Neck 97Head and Neck Neoplasms 89Esophageal Neoplasms 85Triple Negative Breast Neoplasms 84Glioblastoma 80Small Cell Lung Carcinoma 79Endometrial Neoplasms 79Colonic Neoplasms 78Brain Neoplasms 78Melanoma 69Precursor Cell Lymphoblastic Leukemia-Lymphoma 66Hematologic Neoplasms 64Glioma 62Motor Activity 60

Interventions

Specimen Handling 2Biopsy 2ruxolitinib 1prednylidene 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1duvelisib 1deltacortene 1Vincristine 1Prednisone 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Magnetic Resonance Spectroscopy 1Granulocyte Colony-Stimulating Factor 1Fluorodeoxyglucose F18 1Filgrastim 1Doxorubicin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Not yet recruiting × Lymphoma, T-Cell × Clear all
NCT07451054 2026-05-14

CD45BE-HSPC + CART-45 Cells

University of Pennsylvania

Phase 1 Not yet recruiting
42 enrolled
Lymphoid

Hodgkin Disease, Lymphoma, B-Cell, Lymphoma, T-Cell

NCT07538960 2026-04-20

Epidemiology and Management of Cutaneous T-Cell Lymphoma at Hospital México, Costa Rica.

Caja Costarricense de Seguro Social

Not yet recruiting
350 enrolled
DermatologicLymphoid

Lymphoma, T-Cell, Lymphoma, T-Cell, Cutaneous

NCT07339527 2026-01-14

EZH2 Inhibitor Zeprumetostat in Combination Therapy for Patients With Relapsed or Refractory Mature T-cell and NK-cell Lymphomas

Sun Yat-sen University

Phase 1/2 Not yet recruiting
60 enrolled
Lymphoid

Lymphoma, T-Cell

NCT07293403 2025-12-19

Duvelisib Maintenance for the Treatment of Peripheral T-Cell Lymphomas

City of Hope Medical Center

Phase 2 Not yet recruiting
25 enrolled
Lymphoid

Lymphoma, T-Cell

NCT07278856 2025-12-12

Ruxolitinib in Combination With CHOP Chemotherapy for the Treatment of Untreated Nodal T-Follicular Helper Cell Lymphomas

City of Hope Medical Center

Phase 1 Not yet recruiting
20 enrolled
Lymphoid

Lymphoma, T-Cell

NCT07117305 2025-08-12

CD7 CAR-T Combined With Autologous Hematopoietic Stem Cell Transplantation

Zhengzhou University

Phase 1/2 Not yet recruiting
38 enrolled
Lymphoid

Lymphoma, T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡